Effect of methotrexate and folinic acid on skeletal growth in mice.
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000494:pharmacology*; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000494:pharmacology*; D001846:Bone Development / Q000187:drug effects*; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D004912:Erythrocytes / Q000737:chemistry; D005269:Femur / Q000254:growth & development; D005492:Folic Acid / Q000097:blood; D006132:Growth Plate / Q000187:drug effects; D002955:Leucovorin / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000494:pharmacology*; D051379:Mice; D008807:Mice, Inbred BALB C; D013977:Tibia / Q000254:growth & development
D000964:Antimetabolites, Antineoplastic; D018501:Antirheumatic Agents; D004791:Enzyme Inhibitors; D005492:Folic Acid; D002955:Leucovorin; D008727:Methotrexate